Free Trial

HUTCHMED (HCM) Competitors

HUTCHMED logo
GBX 256 +15.00 (+6.22%)
As of 02/21/2025 11:46 AM Eastern

HCM vs. SOPH, ITH, GRI, INDV, SLS, ERGO, BMY, SLN, AMYT, and GPH

Should you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Sophos Group plc (SOPH.L) (SOPH), Ithaca Energy (ITH), Grainger (GRI), Indivior (INDV), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Bloomsbury Publishing (BMY), Silence Therapeutics (SLN), Amryt Pharma (AMYT), and Global Ports (GPH). These companies are all part of the "pharmaceutical products" industry.

HUTCHMED vs.

HUTCHMED (LON:HCM) and Sophos Group plc (SOPH.L) (LON:SOPH) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, community ranking, risk, media sentiment and institutional ownership.

In the previous week, HUTCHMED had 1 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 1 mentions for HUTCHMED and 0 mentions for Sophos Group plc (SOPH.L). HUTCHMED's average media sentiment score of 1.11 beat Sophos Group plc (SOPH.L)'s score of 0.00 indicating that HUTCHMED is being referred to more favorably in the media.

Company Overall Sentiment
HUTCHMED Positive
Sophos Group plc (SOPH.L) Neutral

Sophos Group plc (SOPH.L) has lower revenue, but higher earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HUTCHMED£771.01M3.60-£52.98M-£3.92-65.34
Sophos Group plc (SOPH.L)£726.90M0.00N/A£1.70N/A

Sophos Group plc (SOPH.L) received 221 more outperform votes than HUTCHMED when rated by MarketBeat users. Likewise, 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote while only 78.40% of users gave HUTCHMED an outperform vote.

CompanyUnderperformOutperform
HUTCHMEDOutperform Votes
196
78.40%
Underperform Votes
54
21.60%
Sophos Group plc (SOPH.L)Outperform Votes
417
80.19%
Underperform Votes
103
19.81%

36.5% of HUTCHMED shares are held by institutional investors. 39.0% of HUTCHMED shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to HUTCHMED's net margin of -6.87%. Sophos Group plc (SOPH.L)'s return on equity of 0.00% beat HUTCHMED's return on equity.

Company Net Margins Return on Equity Return on Assets
HUTCHMED-6.87% -5.71% -5.90%
Sophos Group plc (SOPH.L) N/A N/A N/A

Summary

Sophos Group plc (SOPH.L) beats HUTCHMED on 7 of the 12 factors compared between the two stocks.

Get HUTCHMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCM vs. The Competition

MetricHUTCHMEDDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£2.78B£2.35B£5.85B£2.63B
Dividend Yield4.63%2.92%4.76%4.98%
P/E Ratio-65.344.2716.51163.28
Price / Sales3.60733.09450.02312,084.15
Price / Cash2.4910.2538.0128.02
Price / Book2.937.507.645.14
Net Income-£52.98M£20.70B£3.18B£5.73B
7 Day Performance17.43%0.03%-1.95%-0.99%
1 Month Performance9.40%0.15%-0.23%-0.81%
1 Year Performance4.92%98.05%16.69%39.26%

HUTCHMED Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCM
HUTCHMED
N/AGBX 256
+6.2%
N/A+11.8%£2.78B£771.01M-65.341,760High Trading Volume
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
ITH
Ithaca Energy
N/AGBX 131.20
-0.6%
N/A+1.2%£2.16B£1.91B1,093.33220News Coverage
GRI
Grainger
3.1213 of 5 stars
GBX 215.50
-1.4%
GBX 317.50
+47.3%
-20.4%£1.59B£270.30M8,183.33372Dividend Increase
INDV
Indivior
2.5015 of 5 stars
GBX 765
+0.1%
GBX 1,650
+115.7%
-49.2%£983.71M£1.15B-956.251,000News Coverage
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
BMY
Bloomsbury Publishing
3.3803 of 5 stars
GBX 654
+1.2%
GBX 825
+26.1%
+22.6%£532.62M£342.65M1,676.9234,300
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
GPH
Global Ports
N/AN/AN/AN/A£231.21M£193.58M30,000.0020

Related Companies and Tools


This page (LON:HCM) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners